144 related articles for article (PubMed ID: 2988621)
21. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
Kinoshita M; Saito N; Noto T; Tamaki H
J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
[TBL] [Abstract][Full Text] [Related]
22. SCH28080 prevents omeprazole inhibition of the gastric H+/K+-ATPase.
Hersey SJ; Steiner L; Mendlein J; Rabon E; Sachs G
Biochim Biophys Acta; 1988 Aug; 956(1):49-57. PubMed ID: 2841979
[TBL] [Abstract][Full Text] [Related]
23. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
Lamers CB
Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
[No Abstract] [Full Text] [Related]
24. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
[TBL] [Abstract][Full Text] [Related]
25. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles.
Beil W; Sewing KF
Br J Pharmacol; 1984 Jul; 82(3):651-7. PubMed ID: 6146367
[TBL] [Abstract][Full Text] [Related]
27. Disulfide cross-linking of H,K-ATPase opens Cl- conductance, triggering proton uptake in gastric vesicles. Studies with specific inhibitors.
Takeguchi N; Yamazaki Y
J Biol Chem; 1986 Feb; 261(6):2560-6. PubMed ID: 3005257
[TBL] [Abstract][Full Text] [Related]
28. Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+, K(+)-ATPase.
Mendlein J; Sachs G
J Biol Chem; 1990 Mar; 265(9):5030-6. PubMed ID: 2156860
[TBL] [Abstract][Full Text] [Related]
29. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
Nagaya H; Satoh H; Kubo K; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):799-805. PubMed ID: 2537417
[TBL] [Abstract][Full Text] [Related]
30. [Discovery and development of the proton pump inhibitor].
Igata H; Okabe S
Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
[TBL] [Abstract][Full Text] [Related]
31. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
Keeling DJ; Laing SM; Senn-Bilfinger J
Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
[TBL] [Abstract][Full Text] [Related]
32. Catalysis of oxygen-18 exchange between inorganic phosphate and water by the gastric H,K-ATPase.
Faller LD; Elgavish GA
Biochemistry; 1984 Dec; 23(26):6584-90. PubMed ID: 6099142
[TBL] [Abstract][Full Text] [Related]
33. [Studies on the inhibitory action of leminoprazole against rabbit gastric H+,K(+)-ATPase].
Masuda M; Uchida A; Matsukura H; Kamishiro T
Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):325-35. PubMed ID: 7959423
[TBL] [Abstract][Full Text] [Related]
34. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.
Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E
Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064
[TBL] [Abstract][Full Text] [Related]
35. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
Shin JM; Sachs G
Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
Briving C; Andersson BM; Nordberg P; Wallmark B
Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
[TBL] [Abstract][Full Text] [Related]
37. A substituted thieno[3.4-d]imidazole versus substituted benzimidazoles as H+, K+-ATPase inhibitors.
Herling AW; Bickel M; Lang HJ; Weidmann K; Rösner M; Metzger H; Rippel R; Nimmesgern H; Scheunemann KH
Pharmacology; 1988; 36(5):289-97. PubMed ID: 2841691
[TBL] [Abstract][Full Text] [Related]
38. Binding site of omeprazole in hog gastric H+,K(+)-ATPase.
Morii M; Takata H; Takeguchi N
Biochem Biophys Res Commun; 1990 Mar; 167(2):754-60. PubMed ID: 2157414
[TBL] [Abstract][Full Text] [Related]
39. The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.
Wallmark B; Larsson H; Humble L
J Biol Chem; 1985 Nov; 260(25):13681-4. PubMed ID: 2997178
[TBL] [Abstract][Full Text] [Related]
40. The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation.
Keeling DJ; Fallowfield C; Underwood AH
Biochem Pharmacol; 1987 Feb; 36(3):339-44. PubMed ID: 3028428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
